Qianqian Ma

Clinical efficacy and safety of T-DM1 for patients with HER2-positive breast cancer

Xiaohong Wang, Huiying Zhang, Guolei Zhang, 2016, OncoTargets and therapy.

Targeting TPX2 suppresses proliferation and promotes apoptosis via repression of the PI3k/AKT/P21 signaling pathway and activation of p53 pathway in breast cancer.

Ailing Zhong, Hongqin Zhang, Su-hong Xie, 2018, Biochemical and biophysical research communications.

Molecular profiling of mucinous epithelial ovarian cancer by weighted gene co-expression network analysis.

Ailing Zhong, Hui Zheng, M. Chen, 2019, Gene.

Elevated serum HER‐2 predicts poor prognosis in breast cancer and is correlated to ADAM10 expression

Ailing Zhong, Hui Zheng, Yanchun Wang, 2019, Cancer medicine.

MYSM1 induces apoptosis and sensitizes TNBC cells to cisplatin via RSK3–phospho-BAD pathway

X. Meng, Hui Zheng, Yanchun Wang, 2022, Cell death discovery.

Downregulation of XBP1 decreases serous ovarian cancer cell viability and enhances sensitivity to oxidative stress by increasing intracellular ROS levels

Ailing Zhong, Hui Zheng, M. Chen, 2019, Oncology letters.

Involvement of spinal SIRT1 in development of chronic constriction injury induced neuropathic pain in rats.

Hui Zheng, Q. Ma, Juan Zhang, 2018, International journal of clinical and experimental pathology.

ADAM12 expression predicts clinical outcome in estrogen receptor-positive breast cancer.

Xiaohong Wang, A. Mueck, H. Seeger, 2015, International journal of clinical and experimental pathology.